Female, N (%) | Male, N (%) | All, N (%) | |
---|---|---|---|
Number of patients | 79 (35.9) | 141 (64.1) | 220 |
Age at diagnosis (years) | |||
Median | 77 | 72 | 74 |
Range | 33–93 | 43–90 | 33–93 |
Site of primary tumour | |||
Distal oesophagus | 4 (5.1) | 16 (11.3) | 20 (9.1) |
GOJ/cardia | 17 (21.5) | 46 (32.6) | 63 (28.6) |
Corpus | 21 (26.6) | 44 (31.2) | 65 (29.5) |
Antrum/pylorus | 37 (46.8) | 35 (24.8) | 72 (32.7) |
Tumour differentiation grade | |||
Grade 1 | 14 (17.7) | 16 (11.3) | 30 (13.6) |
Grade 2 | 33 (41.8) | 70 (49.6) | 103 (46.8) |
Grade 3 | 32 (40.5) | 55 (39.0) | 87 (39.5) |
Stage at diagnosis | |||
IA | 15 (19.0) | 18 (12.8) | 33 (15.0) |
IB | 7 (8.9) | 19 (13.5) | 26 (11.8) |
IIA | 17 (21.5) | 33 (23.4) | 50 (22.7) |
IIB | 14 (17.7) | 19 (13.5) | 33 (15.0) |
IIIA | 7 (8.9) | 21 (14.9) | 28 (12.7) |
IIIB | 11 (13.9) | 19 (13.5) | 30 (13.6) |
IIIC | 1 (1.3) | 5 (3.5) | 6 (2.7) |
IV | 7 (8.9) | 7 (5.0) | 14 (6.4) |
Residual tumour classification | |||
R0 (no residual tumour) | 62 (78.5) | 105 (74.5) | 167 (75.9) |
R1 (microscopic residual tumour) | 5 (6.3) | 19 (13.5) | 24 (10.9) |
R2 (macroscopic residual tumour) | 8 (10.1) | 9 (6.4) | 17 (7.7) |
Rx (unknown) | 4 (5.1) | 8 (5.7) | 12 (5.5) |
Perioperative and adjuvant therapya (N = 206) | |||
Only chemotherapy | 7 (9.7) | 24 (17.9) | 31 (15.0) |
Chemoradiotherapy | 4 (5.6) | 16 (11.9) | 20 (9.7) |
Only radiation therapy | 1 (1.4) | 4 (3.0) | 5 (2.4) |
No adjuvant therapy | 58 (80.6) | 89 (66.4) | 147 (71.4) |
Unknown | 2 (2.8) | 1 (0.7) | 3 (1.5) |
Tumour recurrenceb(N = 195) | |||
No recurrence | 55 (79.7) | 82 (65.1) | 137 (70.3) |
Single metastasis >6 months | 10 (14.5) | 26 (20.6) | 36 (18.5) |
Multiple metastases >6 months | 4 (5.8) | 18 (14.3) | 22 (11.3) |
Follow-up status | |||
Alive and free of disease | 22 (27.8) | 31 (22.0) | 53 (24.1) |
Alive with disease | 1 (1.3) | 1 (0.7) | 2 (0.9) |
Died of disease | 43 (54.4) | 74 (52.5) | 117 (53.2) |
Died of other cause | 12 (15.2) | 30 (21.3) | 42 (19.1) |
Unknown cause of death | 1 (1.3) | 5 (3.5) | 6 (2.7) |